Autolus Therapeutics Unrealized Gain (Loss) on Investment Securities (Quarterly) Analysis

Autolus Therapeutics Plc (AUTL)

1.57 +0.01 (+0.64%) USD | NASDAQ | Dec 18, 16:00

1.575 0.00 (0.00%) After-Hours: 20:00

View Unrealized Gain (Loss) on Investment Securities (Quarterly) for AUTL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Benchmarks

Start Trial

Adaptimmune Therapeutics Plc	--
Biodexa Pharmaceuticals Plc	--
NuCana Plc	--
Mereo BioPharma Group Plc	--
Bicycle Therapeutics Plc	--